ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QA08...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
[edit] A08A Antiobesity preparations, excluding diet products
[edit] A08AA Centrally acting antiobesity products
- A08AA01 Phentermine
- A08AA02 Fenfluramine
- A08AA03 Amfepramone
- A08AA04 Dexfenfluramine
- A08AA05 Mazindol
- A08AA06 Etilamfetamine
- A08AA07 Cathine
- A08AA08 Clobenzorex
- A08AA09 Mefenorex
- A08AA10 Sibutramine
- A08AA56 Ephedrine, combinations
[edit] A08AB Peripherally acting antiobesity products
- A08AB01 Orlistat
- QA08AB90 Mitratapide
- QA08AB91 Dirlotapide
[edit] A08AX Other antiobesity drugs
- A08AX01 Rimonabant
[edit] See also
- Diet products are in the ATC group V06A.
[edit] References
